Immunotherapy for SARS-CoV-2: potential opportunities

Mehrnoosh Pashaei¹, Nima Rezaei^{1

2

3}

Affiliations

¹ Department of Immunology, School of Medicine, Tehran University of Medical Sciences , Tehran, Iran.
² Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN) , Tehran, Iran.
³ Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences , Tehran, Iran.

Editorial

Mehrnoosh Pashaei et al. Expert Opin Biol Ther. 2020 Oct.

. 2020 Oct;20(10):1111-1116.

doi: 10.1080/14712598.2020.1807933. Epub 2020 Aug 12.

Mehrnoosh Pashaei¹, Nima Rezaei^{1

2

3}

¹ Department of Immunology, School of Medicine, Tehran University of Medical Sciences , Tehran, Iran.
² Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN) , Tehran, Iran.
³ Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences , Tehran, Iran.

No abstract available

Keywords: COVID-19; Immunotherapy; monoclonal antibodies; severe acute respiratory syndrome coronavirus 2.

Comment on

An Update on Current Therapeutic Drugs Treating COVID-19.
Wu R, Wang L, Kuo HD, Shannar A, Peter R, Chou PJ, Li S, Hudlikar R, Liu X, Liu Z, Poiani GJ, Amorosa L, Brunetti L, Kong AN. Wu R, et al. Curr Pharmacol Rep. 2020;6(3):56-70. doi: 10.1007/s40495-020-00216-7. Epub 2020 May 11. Curr Pharmacol Rep. 2020. PMID: 32395418 Free PMC article. Review.
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids.
Saghazadeh A, Rezaei N. Saghazadeh A, et al. Int Immunopharmacol. 2020 Jul;84:106560. doi: 10.1016/j.intimp.2020.106560. Epub 2020 May 8. Int Immunopharmacol. 2020. PMID: 32413736 Free PMC article. Review.

1. Hanaei S, Rezaei N.. COVID-19: developing from an outbreak to a pandemic. Arch Med Res. 2020. DOI:10.1016/j.arcmed.2020.04.021 - DOI - PMC - PubMed
1. Jabbari P, Jabbari F, Ebrahimi S, et al. COVID-19: a chimera of two pandemics. Disaster Med Public Health Prep. 2020;1–3. - PMC - PubMed
1. Zu ZY, Jiang MD, Xu PP, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 2020;200490. - PMC - PubMed
1. Satija N, Lal SK.. The molecular biology of SARS coronavirus. Ann N Y Acad Sci. 2007;1102(1):26. - PMC - PubMed
1. Lotfi M, Rezaei N.. SARS-CoV-2: a comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol. 2020. DOI:10.1002/jmv.26123•A comprehensive review from pathogenicity of SARS-CoV-2 to clinical consequences. - DOI - PMC - PubMed